Evaluation of the ACT day clinic at Vivantes Klinikum Kaulsdorf

Evaluation of the ACT day clinic at Vivantes Klinikum Kaulsdorf - Evalu-ACT

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029992

Enrollment

118

Registered

2022-08-19

Start date

2020-03-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F99

Interventions

Group 1: Patients of a transdiagnostic general psychiatric day clinic with acceptance and commitment therapy as a treatment concept receive a set of questionnaires on the day of admission, on the day

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: - Filling in the questionnaires too late (more than two days after admission) - Treatment duration of less than 38 days - Admission to the clinic before the start of COVID restrictions (March 16, 2020).

Design outcomes

Primary

Measure	Time frame
Symptom reduction: Beck Depression Inventory - Revision (BDI-II) and Symptom Checklist (SCL-90-S). T1: admission day T2: discharge T3: 3-month follow-up	—

Secondary

Measure	Time frame
Psychological flexibility: Acceptance and Action Questionnaire (AAQ II) (T1, T2, T3) Quality of life: World Health Organization Quality of Life - Short Version (WHOQOL-BREF) (T1, T2, T3) Global level of functioning: Global Assessment of Functioning Scale (GAF) (T1, T2) Adverse effects: Inventory for the Assessment of Negative Effects after Psychotherapy (INEP) (T3)	—

Countries

Germany

Contacts

Public ContactChristoph Richter

Klinik für Psychiatrie, Psychotherapie und Psychosomatik Vivantes - Klinikum Kaulsdorf

christoph.richter@vivantes.de030/130173001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026